The once exorbitantly priced drug, originally costing 1.29 million yuan per vial, is now covered by medical insurance.
2026-11-14 11:06:13
According to CoinMeta, on November 14th, the National Healthcare Security Administration announced that Wuxi AppTec's CAR-T drug, Rykioleucel, has been included in the medical insurance catalog. Before its inclusion in medical insurance, the price of Rykioleucel was 1.29 million yuan per vial. Ma Jun, the director of the Harbin Institute of Hematology and Oncology, participated in the review of the Rykioleucel project and the formulation of clinical application guidelines. He stated that after its inclusion in medical insurance, the price of Rykioleucel has been reduced to below 300,000 yuan per vial.
Bullish 1
Bearish 0
Source:Jin10 Data
This content is for market information only and does not constitute investment advice.